Cargando…
Establishment of a type II insulin-like growth factor receptor gene site-integrated SKBR3 cell line using CRISPR/Cas9
Human epidermal growth factor receptor 2 (HER-2)(+) breast cancer has a high recurrence rate and a poor prognosis, with drug resistance contributing to disease progression. The present study aimed to establish a SKBR3 cell line with type II insulin-like growth factor receptor (IGR-IIR) gene site int...
Autores principales: | Ma, Xinyu, Cao, Ru, Xiao, Haiyan, Cao, Zhongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586281/ https://www.ncbi.nlm.nih.gov/pubmed/33123265 http://dx.doi.org/10.3892/ol.2020.12216 |
Ejemplares similares
-
Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites
por: Tao, Jianli, et al.
Publicado: (2022) -
Honokiol inhibits the growth of SKBR3 cells
por: Shi, He, et al.
Publicado: (2020) -
Application of CRISPR/Cas9 System in Establishing Large Animal Models
por: Lin, Yingqi, et al.
Publicado: (2022) -
CRISPR/Cas9 establishment-mediated targeted mutagenesis in Macrobrachium nipponense
por: Qiao, Hui, et al.
Publicado: (2023) -
Establishment of CRISPR-Cas9 system in Bifidobacteria animalis AR668
por: Li, Jiao, et al.
Publicado: (2023)